Fludarabine Compared with Chlorambucil as Primary Therapy for Chronic Lymphocytic Leukemia
2000; Massachusetts Medical Society; Volume: 343; Issue: 24 Linguagem: Inglês
10.1056/nejm200012143432402
ISSN1533-4406
AutoresR. Kanti, Bercedis L. Peterson, Frederick R. Appelbaum, Jonathan E. Kolitz, Laurence Elias, Lois E. Shepherd, John Hines, Gregory A. Threatte, Richard A. Larson, Bruce D. Cheson, Charles A. Schiffer,
Tópico(s)Immunodeficiency and Autoimmune Disorders
ResumoFludarabine is an effective treatment for chronic lymphocytic leukemia that does not respond to initial treatment with chlorambucil. We compared the efficacy of fludarabine with that of chlorambucil in the primary treatment of chronic lymphocytic leukemia.
Referência(s)